Source comparison
Best TB-500 Dosage Flexibility 2026: Administration Route Comparison
Subcutaneous (SC) 12–18 hours gradual absorption 8–12 hours post-injection Abdominal fat, anterior/lateral thigh, tricep area 27–30 gauge Minimal. Suitable for long-term protocols Maintenance phases, chronic condition protocols, patient comfort priority Equiva
This comparison does not assign a generated winner or score.
- Subcutaneous (SC)
- 12–18 hours gradual absorption
- 8–12 hours post-injection
- Abdominal fat, anterior/lateral thigh, tricep area
- 27–30 gauge
- Minimal. Suitable for long-term protocols
- Maintenance phases, chronic condition protocols, patient comfort priority
- Equivalent bioavailability to IM with better long-term tolerability. Our team's default for protocols beyond 12 weeks
- Intramuscular (IM)
- 4–8 hours faster initial uptake
- 4–6 hours post-injection
- Deltoid, vastus lateralis, gluteus medius
- 23–25 gauge
- Moderate. Rotation essential
- Loading phases, acute injury protocols, rapid saturation needed
- Faster plasma concentration useful in loading phases, but no efficacy advantage over SC in maintenance. Switch to SC after week 6 to reduce cumulative injection site stress
- Intravenous (IV)
- Immediate. Not recommended for TB-500
- <30 minutes
- Requires clinical setting
- 20–22 gauge
- Requires vascular access
- Research settings only. Not standard protocol
- TB-500's long half-life makes IV administration unnecessary. SC/IM routes achieve the same steady-state concentrations within 72 hours without the complexity or risk of IV access